

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.38236501 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.38236501 |
| 3 | behavioral response to nicotine (GO:0035095) | 6.08236029 |
| 4 | aromatic amino acid family catabolic process (GO:0009074) | 6.02362062 |
| 5 | tryptophan catabolic process (GO:0006569) | 5.76725602 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.76725602 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.76725602 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.68851021 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.68851021 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.52437312 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.09276284 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.05675698 |
| 13 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.95792662 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.94986148 |
| 15 | urea cycle (GO:0000050) | 4.64752205 |
| 16 | urea metabolic process (GO:0019627) | 4.64752205 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 4.64006014 |
| 18 | cellular biogenic amine catabolic process (GO:0042402) | 4.50631481 |
| 19 | amine catabolic process (GO:0009310) | 4.50631481 |
| 20 | bile acid metabolic process (GO:0008206) | 4.43182848 |
| 21 | tyrosine metabolic process (GO:0006570) | 4.38521725 |
| 22 | aromatic amino acid family metabolic process (GO:0009072) | 4.34327651 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.33922214 |
| 24 | regulation of cholesterol esterification (GO:0010872) | 4.33674592 |
| 25 | indolalkylamine metabolic process (GO:0006586) | 4.32382548 |
| 26 | complement activation, alternative pathway (GO:0006957) | 4.30397665 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.29567849 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.27499218 |
| 29 | glyoxylate metabolic process (GO:0046487) | 4.18391185 |
| 30 | nucleobase catabolic process (GO:0046113) | 4.09196492 |
| 31 | regulation of bile acid biosynthetic process (GO:0070857) | 4.07722311 |
| 32 | NAD biosynthetic process (GO:0009435) | 4.06117384 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.03321672 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.03273891 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.00952878 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.00952878 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.00952878 |
| 38 | coenzyme catabolic process (GO:0009109) | 4.00684756 |
| 39 | negative regulation of telomere maintenance (GO:0032205) | 4.00670782 |
| 40 | regulation of complement activation (GO:0030449) | 3.96505071 |
| 41 | cholesterol efflux (GO:0033344) | 3.95196407 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.94708709 |
| 43 | DNA deamination (GO:0045006) | 3.94686092 |
| 44 | imidazole-containing compound metabolic process (GO:0052803) | 3.93091708 |
| 45 | postsynaptic membrane organization (GO:0001941) | 3.88655493 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.86482400 |
| 47 | bile acid and bile salt transport (GO:0015721) | 3.85866200 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 3.82696348 |
| 49 | phospholipid efflux (GO:0033700) | 3.81105442 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.80677291 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.79557981 |
| 52 | triglyceride homeostasis (GO:0070328) | 3.79557981 |
| 53 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77330387 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.76292742 |
| 55 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.73797931 |
| 56 | protein carboxylation (GO:0018214) | 3.73797931 |
| 57 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.73183180 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69233525 |
| 59 | cellular glucuronidation (GO:0052695) | 3.65728598 |
| 60 | blood coagulation, intrinsic pathway (GO:0007597) | 3.65066906 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 3.61734640 |
| 62 | negative regulation of lipase activity (GO:0060192) | 3.60844182 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.57578111 |
| 64 | glutamate metabolic process (GO:0006536) | 3.51987422 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.50821687 |
| 66 | cysteine metabolic process (GO:0006534) | 3.50062651 |
| 67 | L-fucose metabolic process (GO:0042354) | 3.49468602 |
| 68 | L-fucose catabolic process (GO:0042355) | 3.49468602 |
| 69 | fucose catabolic process (GO:0019317) | 3.49468602 |
| 70 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.49166017 |
| 71 | axonal fasciculation (GO:0007413) | 3.47294758 |
| 72 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.46143160 |
| 73 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.46143160 |
| 74 | negative regulation of cholesterol transport (GO:0032375) | 3.43208866 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.43208866 |
| 76 | drug catabolic process (GO:0042737) | 3.41237413 |
| 77 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.39107741 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.38420042 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.37224931 |
| 80 | neuron cell-cell adhesion (GO:0007158) | 3.37187545 |
| 81 | negative regulation of protein activation cascade (GO:2000258) | 3.37057079 |
| 82 | arginine metabolic process (GO:0006525) | 3.36854976 |
| 83 | activated T cell proliferation (GO:0050798) | 3.36746228 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.34640138 |
| 85 | sulfur amino acid catabolic process (GO:0000098) | 3.33548235 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.31556760 |
| 87 | intestinal cholesterol absorption (GO:0030299) | 3.29757794 |
| 88 | epithelial cilium movement (GO:0003351) | 3.22009157 |
| 89 | fatty acid elongation (GO:0030497) | 3.21260104 |
| 90 | glucuronate metabolic process (GO:0019585) | 3.21226591 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.21226591 |
| 92 | indole-containing compound metabolic process (GO:0042430) | 3.21097403 |
| 93 | synaptic transmission, cholinergic (GO:0007271) | 3.19020036 |
| 94 | protein activation cascade (GO:0072376) | 3.18754742 |
| 95 | nonmotile primary cilium assembly (GO:0035058) | 3.16772626 |
| 96 | response to pheromone (GO:0019236) | 3.16482538 |
| 97 | presynaptic membrane assembly (GO:0097105) | 3.12040458 |
| 98 | very long-chain fatty acid metabolic process (GO:0000038) | 3.11973919 |
| 99 | synapse assembly (GO:0007416) | 3.08482187 |
| 100 | phospholipid homeostasis (GO:0055091) | 3.08065544 |
| 101 | startle response (GO:0001964) | 3.07554717 |
| 102 | opsonization (GO:0008228) | 3.07142692 |
| 103 | presynaptic membrane organization (GO:0097090) | 3.06823359 |
| 104 | plasma lipoprotein particle organization (GO:0071827) | 3.06206677 |
| 105 | cofactor catabolic process (GO:0051187) | 3.05291595 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.05195439 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.05195439 |
| 108 | retinal ganglion cell axon guidance (GO:0031290) | 3.02912943 |
| 109 | regulation of action potential (GO:0098900) | 3.02260645 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.01504348 |
| 111 | neuronal action potential (GO:0019228) | 2.99524408 |
| 112 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.98747722 |
| 113 | cholesterol homeostasis (GO:0042632) | 2.97945937 |
| 114 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.97489864 |
| 115 | flavonoid metabolic process (GO:0009812) | 2.97467670 |
| 116 | positive regulation of mitochondrial fission (GO:0090141) | 2.96485387 |
| 117 | regulation of telomere maintenance (GO:0032204) | 2.96388562 |
| 118 | plasma lipoprotein particle clearance (GO:0034381) | 2.96378552 |
| 119 | complement activation (GO:0006956) | 2.96151449 |
| 120 | neuron recognition (GO:0008038) | 2.95412263 |
| 121 | neural tube formation (GO:0001841) | 2.93455820 |
| 122 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.92978971 |
| 123 | cellular ketone body metabolic process (GO:0046950) | 2.91548390 |
| 124 | auditory behavior (GO:0031223) | 2.90936807 |
| 125 | sterol homeostasis (GO:0055092) | 2.90831033 |
| 126 | protein polyglutamylation (GO:0018095) | 2.90507720 |
| 127 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89400312 |
| 128 | exogenous drug catabolic process (GO:0042738) | 2.88741647 |
| 129 | transmission of nerve impulse (GO:0019226) | 2.88051782 |
| 130 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.87051140 |
| 131 | protein localization to synapse (GO:0035418) | 2.86927242 |
| 132 | cytolysis (GO:0019835) | 2.86568854 |
| 133 | organic acid catabolic process (GO:0016054) | 2.85611329 |
| 134 | carboxylic acid catabolic process (GO:0046395) | 2.85611329 |
| 135 | forebrain neuron differentiation (GO:0021879) | 2.85097643 |
| 136 | somite development (GO:0061053) | 2.83689604 |
| 137 | olfactory bulb development (GO:0021772) | 2.83630201 |
| 138 | fibrinolysis (GO:0042730) | 2.83512943 |
| 139 | cellular modified amino acid catabolic process (GO:0042219) | 2.82653706 |
| 140 | neuronal stem cell maintenance (GO:0097150) | 2.79675713 |
| 141 | spinal cord development (GO:0021510) | 2.79645970 |
| 142 | platelet dense granule organization (GO:0060155) | 2.79611208 |
| 143 | dendritic spine morphogenesis (GO:0060997) | 2.73764466 |
| 144 | protein localization to cilium (GO:0061512) | 2.73565895 |
| 145 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.72780051 |
| 146 | neuron fate determination (GO:0048664) | 2.71902316 |
| 147 | cell differentiation in spinal cord (GO:0021515) | 2.71606456 |
| 148 | growth hormone secretion (GO:0030252) | 2.71088796 |
| 149 | positive regulation of growth hormone secretion (GO:0060124) | 2.67620548 |
| 150 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.67065572 |
| 151 | NADH dehydrogenase complex assembly (GO:0010257) | 2.67065572 |
| 152 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.67065572 |
| 153 | ubiquinone metabolic process (GO:0006743) | 2.66773895 |
| 154 | cilium movement (GO:0003341) | 2.66528439 |
| 155 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.66218325 |
| 156 | head development (GO:0060322) | 2.63802652 |
| 157 | vocalization behavior (GO:0071625) | 2.62978374 |
| 158 | protein complex biogenesis (GO:0070271) | 2.61607262 |
| 159 | pyrimidine dimer repair (GO:0006290) | 2.59829755 |
| 160 | sequestering of actin monomers (GO:0042989) | 2.59741075 |
| 161 | spinal cord association neuron differentiation (GO:0021527) | 2.59721026 |
| 162 | regulation of mitochondrial fission (GO:0090140) | 2.59305059 |
| 163 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.59294220 |
| 164 | ubiquinone biosynthetic process (GO:0006744) | 2.58862753 |
| 165 | cilium morphogenesis (GO:0060271) | 2.58197364 |
| 166 | protein-cofactor linkage (GO:0018065) | 2.56167274 |
| 167 | reflex (GO:0060004) | 2.54396049 |
| 168 | spinal cord motor neuron differentiation (GO:0021522) | 2.54218480 |
| 169 | reciprocal DNA recombination (GO:0035825) | 2.53721162 |
| 170 | reciprocal meiotic recombination (GO:0007131) | 2.53721162 |
| 171 | cytidine catabolic process (GO:0006216) | 2.53341708 |
| 172 | cytidine deamination (GO:0009972) | 2.53341708 |
| 173 | cytidine metabolic process (GO:0046087) | 2.53341708 |
| 174 | nephron tubule morphogenesis (GO:0072078) | 2.52479654 |
| 175 | nephron epithelium morphogenesis (GO:0072088) | 2.52479654 |
| 176 | establishment of protein localization to Golgi (GO:0072600) | 2.52192224 |
| 177 | primary amino compound metabolic process (GO:1901160) | 2.51071494 |
| 178 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.50989421 |
| 179 | mannosylation (GO:0097502) | 2.50724278 |
| 180 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.49780599 |
| 181 | axoneme assembly (GO:0035082) | 2.49670474 |
| 182 | kidney morphogenesis (GO:0060993) | 2.49510492 |
| 183 | protein K11-linked deubiquitination (GO:0035871) | 2.49232501 |
| 184 | intraciliary transport (GO:0042073) | 2.49034126 |
| 185 | membrane depolarization during action potential (GO:0086010) | 2.48086111 |
| 186 | photoreceptor cell maintenance (GO:0045494) | 2.47172834 |
| 187 | negative regulation of mast cell activation (GO:0033004) | 2.46852898 |
| 188 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.45947809 |
| 189 | photoreceptor cell development (GO:0042461) | 2.45420036 |
| 190 | thalamus development (GO:0021794) | 2.45358092 |
| 191 | regulation of cilium movement (GO:0003352) | 2.44565275 |
| 192 | positive regulation of synapse assembly (GO:0051965) | 2.42274611 |
| 193 | cilium organization (GO:0044782) | 2.42223807 |
| 194 | serotonin metabolic process (GO:0042428) | 2.42202715 |
| 195 | DNA double-strand break processing (GO:0000729) | 2.41936023 |
| 196 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.40211505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.81866669 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.13090748 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.87785373 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84555796 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60945612 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.92935409 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.82009842 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.72632478 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.63786509 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.50740479 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.42618522 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.39438884 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.36110416 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30862487 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.18702553 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.09034488 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.98446360 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.90494924 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.87210097 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.87039393 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82885427 |
| 22 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76914862 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73901177 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.71137610 |
| 25 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.69441278 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67918492 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63647527 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62397330 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62362335 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60646705 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60245006 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60177654 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.59986416 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59789461 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.58926720 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58561932 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.55915703 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54807784 |
| 39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54409574 |
| 40 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.53454310 |
| 41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53311961 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53074095 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52472845 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.52142516 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51945476 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51794037 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.51365460 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51136802 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49024623 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.48219356 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47188825 |
| 52 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46054513 |
| 53 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.45205084 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44406049 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.43913274 |
| 56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42855038 |
| 57 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.42256701 |
| 58 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.40889990 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40694079 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40381636 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39747570 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37869792 |
| 63 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.36453007 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35568974 |
| 65 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.35137806 |
| 66 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35046446 |
| 67 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.34773470 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34624519 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34550405 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33608794 |
| 71 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.33518011 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32741437 |
| 73 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.32712436 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32543379 |
| 75 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.32139014 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31734264 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29835237 |
| 78 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28328556 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27628194 |
| 80 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27628194 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27410907 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.27080273 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27009076 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26428656 |
| 85 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24683445 |
| 86 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24192922 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22421691 |
| 88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22337569 |
| 89 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21789643 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20750720 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20750720 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20494780 |
| 93 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20399061 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19187617 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19110087 |
| 96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19096020 |
| 97 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19037454 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18790853 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18126190 |
| 100 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.16886530 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16726514 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12514842 |
| 103 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.12111128 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11888970 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11847094 |
| 106 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.11716271 |
| 107 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11392574 |
| 108 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11277876 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11028280 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11002155 |
| 111 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10763991 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10457784 |
| 113 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10273535 |
| 114 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09808524 |
| 115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09370145 |
| 116 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.09280483 |
| 117 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09216659 |
| 118 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08924797 |
| 119 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.08494050 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07731588 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07167890 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06911036 |
| 123 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.06492877 |
| 124 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05309421 |
| 125 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.05238742 |
| 126 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04946280 |
| 127 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04946280 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04917152 |
| 129 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.04538140 |
| 130 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02980356 |
| 131 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.01751454 |
| 132 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00816353 |
| 133 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.98805345 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98251981 |
| 135 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96936581 |
| 136 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95933821 |
| 137 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95275932 |
| 138 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94436994 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92411967 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91571749 |
| 141 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90671859 |
| 142 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90671859 |
| 143 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90564930 |
| 144 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90461523 |
| 145 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90461523 |
| 146 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87711762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.95380083 |
| 2 | MP0005360_urolithiasis | 6.26496654 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.44094606 |
| 4 | MP0005365_abnormal_bile_salt | 4.74845073 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.09918120 |
| 6 | MP0003122_maternal_imprinting | 3.19072439 |
| 7 | MP0003252_abnormal_bile_duct | 3.15656477 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.77693340 |
| 9 | MP0009697_abnormal_copulation | 2.66773739 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.30347941 |
| 11 | MP0003121_genomic_imprinting | 2.30169551 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.27377155 |
| 13 | MP0002736_abnormal_nociception_after | 2.21038098 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.16339875 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.09115791 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.06939537 |
| 17 | MP0003195_calcinosis | 2.06342920 |
| 18 | MP0000569_abnormal_digit_pigmentation | 1.96888947 |
| 19 | MP0005083_abnormal_biliary_tract | 1.90051712 |
| 20 | MP0005646_abnormal_pituitary_gland | 1.82908872 |
| 21 | MP0005332_abnormal_amino_acid | 1.82256235 |
| 22 | MP0003880_abnormal_central_pattern | 1.78156709 |
| 23 | MP0004133_heterotaxia | 1.76831594 |
| 24 | MP0003868_abnormal_feces_composition | 1.76423980 |
| 25 | MP0001764_abnormal_homeostasis | 1.72078476 |
| 26 | MP0000631_abnormal_neuroendocrine_gland | 1.67469966 |
| 27 | MP0000566_synostosis | 1.67446044 |
| 28 | MP0008995_early_reproductive_senescence | 1.66350967 |
| 29 | MP0004381_abnormal_hair_follicle | 1.63054617 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.62976749 |
| 31 | MP0005253_abnormal_eye_physiology | 1.57021260 |
| 32 | MP0001984_abnormal_olfaction | 1.54549766 |
| 33 | MP0004885_abnormal_endolymph | 1.54061971 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.48979677 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.47465175 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.46289070 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.42555119 |
| 38 | MP0001970_abnormal_pain_threshold | 1.39962346 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.39892084 |
| 40 | MP0001486_abnormal_startle_reflex | 1.35493304 |
| 41 | MP0000609_abnormal_liver_physiology | 1.34357162 |
| 42 | MP0004142_abnormal_muscle_tone | 1.32370889 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.32025975 |
| 44 | MP0009745_abnormal_behavioral_response | 1.31855875 |
| 45 | MP0008872_abnormal_physiological_respon | 1.29030667 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.28905616 |
| 47 | MP0002751_abnormal_autonomic_nervous | 1.28579859 |
| 48 | MP0009840_abnormal_foam_cell | 1.28266641 |
| 49 | MP0009046_muscle_twitch | 1.27733527 |
| 50 | MP0002822_catalepsy | 1.26168586 |
| 51 | MP0005647_abnormal_sex_gland | 1.25756465 |
| 52 | MP0002234_abnormal_pharynx_morphology | 1.22128872 |
| 53 | MP0002163_abnormal_gland_morphology | 1.21816357 |
| 54 | MP0000778_abnormal_nervous_system | 1.19028361 |
| 55 | MP0002752_abnormal_somatic_nervous | 1.18913093 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.18896107 |
| 57 | MP0005408_hypopigmentation | 1.18633949 |
| 58 | MP0002184_abnormal_innervation | 1.18301871 |
| 59 | MP0003011_delayed_dark_adaptation | 1.17433081 |
| 60 | MP0002272_abnormal_nervous_system | 1.17421824 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.16581546 |
| 62 | MP0004147_increased_porphyrin_level | 1.16547758 |
| 63 | MP0004043_abnormal_pH_regulation | 1.16468985 |
| 64 | MP0000049_abnormal_middle_ear | 1.15876875 |
| 65 | MP0003646_muscle_fatigue | 1.14861866 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.14388695 |
| 67 | MP0006292_abnormal_olfactory_placode | 1.14311485 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.12875737 |
| 69 | MP0002064_seizures | 1.12359009 |
| 70 | MP0005451_abnormal_body_composition | 1.11704376 |
| 71 | MP0003283_abnormal_digestive_organ | 1.11696704 |
| 72 | MP0004270_analgesia | 1.11518244 |
| 73 | MP0001188_hyperpigmentation | 1.11327491 |
| 74 | MP0003878_abnormal_ear_physiology | 1.10725755 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 1.10725755 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.10410088 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.09386337 |
| 78 | MP0002938_white_spotting | 1.08623087 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 1.07750809 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 1.05019210 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 1.04642910 |
| 82 | MP0001986_abnormal_taste_sensitivity | 1.03485699 |
| 83 | MP0005195_abnormal_posterior_eye | 1.02248017 |
| 84 | MP0005389_reproductive_system_phenotype | 1.02192417 |
| 85 | MP0003690_abnormal_glial_cell | 1.02015939 |
| 86 | MP0004811_abnormal_neuron_physiology | 1.01950825 |
| 87 | MP0001529_abnormal_vocalization | 1.00693583 |
| 88 | MP0002063_abnormal_learning/memory/cond | 1.00009498 |
| 89 | MP0005409_darkened_coat_color | 0.99193380 |
| 90 | MP0001919_abnormal_reproductive_system | 0.98424961 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98031223 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.95812956 |
| 93 | MP0002160_abnormal_reproductive_system | 0.95807490 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.95108828 |
| 95 | MP0000427_abnormal_hair_cycle | 0.94731609 |
| 96 | MP0002928_abnormal_bile_duct | 0.94076068 |
| 97 | MP0002152_abnormal_brain_morphology | 0.93683170 |
| 98 | MP0004742_abnormal_vestibular_system | 0.92650697 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.91901895 |
| 100 | MP0001440_abnormal_grooming_behavior | 0.89451828 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.89361164 |
| 102 | MP0002067_abnormal_sensory_capabilities | 0.88958308 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.88685920 |
| 104 | MP0000372_irregular_coat_pigmentation | 0.88007237 |
| 105 | MP0009764_decreased_sensitivity_to | 0.87335409 |
| 106 | MP0003119_abnormal_digestive_system | 0.86201196 |
| 107 | MP0002102_abnormal_ear_morphology | 0.85354979 |
| 108 | MP0001661_extended_life_span | 0.85039004 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 0.84433769 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.84389533 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.83753370 |
| 112 | MP0004924_abnormal_behavior | 0.82683427 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.82683427 |
| 114 | MP0003698_abnormal_male_reproductive | 0.79966491 |
| 115 | MP0002909_abnormal_adrenal_gland | 0.79948436 |
| 116 | MP0002735_abnormal_chemical_nociception | 0.79513753 |
| 117 | MP0001968_abnormal_touch/_nociception | 0.78831074 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.78300363 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.76906195 |
| 120 | MP0005423_abnormal_somatic_nervous | 0.75504579 |
| 121 | MP0005171_absent_coat_pigmentation | 0.74266770 |
| 122 | MP0003787_abnormal_imprinting | 0.74134843 |
| 123 | MP0003718_maternal_effect | 0.70712414 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.70331670 |
| 125 | MP0005535_abnormal_body_temperature | 0.70277304 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.69699131 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.69552200 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.69166673 |
| 129 | MP0001905_abnormal_dopamine_level | 0.67603021 |
| 130 | MP0000920_abnormal_myelination | 0.67413530 |
| 131 | MP0001177_atelectasis | 0.67233568 |
| 132 | MP0002734_abnormal_mechanical_nocicepti | 0.67149106 |
| 133 | MP0005448_abnormal_energy_balance | 0.66569348 |
| 134 | MP0001501_abnormal_sleep_pattern | 0.66351672 |
| 135 | MP0005394_taste/olfaction_phenotype | 0.66228430 |
| 136 | MP0005499_abnormal_olfactory_system | 0.66228430 |
| 137 | MP0002229_neurodegeneration | 0.65999050 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.64407940 |
| 139 | MP0005636_abnormal_mineral_homeostasis | 0.64380042 |
| 140 | MP0000026_abnormal_inner_ear | 0.61226438 |
| 141 | MP0000639_abnormal_adrenal_gland | 0.60910835 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.60776082 |
| 143 | MP0002069_abnormal_eating/drinking_beha | 0.60321325 |
| 144 | MP0001324_abnormal_eye_pigmentation | 0.60048245 |
| 145 | MP0003136_yellow_coat_color | 0.58751321 |
| 146 | MP0000955_abnormal_spinal_cord | 0.58737328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 6.16700533 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.15106659 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.52791663 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.28207345 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 5.23906685 |
| 6 | Type II lissencephaly (HP:0007260) | 5.12859859 |
| 7 | Deep venous thrombosis (HP:0002625) | 5.03596523 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.84241929 |
| 9 | Joint hemorrhage (HP:0005261) | 4.38567621 |
| 10 | Complement deficiency (HP:0004431) | 4.21829509 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.18583890 |
| 12 | Xanthomatosis (HP:0000991) | 4.17672822 |
| 13 | Pancreatic cysts (HP:0001737) | 4.11167628 |
| 14 | Epidermoid cyst (HP:0200040) | 4.03316282 |
| 15 | Cerebellar dysplasia (HP:0007033) | 3.95933772 |
| 16 | Retinal dysplasia (HP:0007973) | 3.89602132 |
| 17 | Lissencephaly (HP:0001339) | 3.70286903 |
| 18 | True hermaphroditism (HP:0010459) | 3.64315657 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.62348266 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.62348266 |
| 21 | Pancreatic fibrosis (HP:0100732) | 3.58858027 |
| 22 | Fat malabsorption (HP:0002630) | 3.54019295 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.50298225 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.43070448 |
| 25 | Hyperglycinemia (HP:0002154) | 3.38012032 |
| 26 | Nephronophthisis (HP:0000090) | 3.33489285 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29141056 |
| 28 | Fair hair (HP:0002286) | 3.26945750 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.25687834 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 3.23634516 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.17295830 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.16309030 |
| 33 | Hyperventilation (HP:0002883) | 3.07545653 |
| 34 | Pendular nystagmus (HP:0012043) | 3.07307125 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.06546743 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.02380116 |
| 37 | Hyperglycinuria (HP:0003108) | 2.94085235 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.89947355 |
| 39 | Gait imbalance (HP:0002141) | 2.89604430 |
| 40 | Hypoplasia of the pons (HP:0012110) | 2.88679287 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.88604664 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88604664 |
| 43 | Febrile seizures (HP:0002373) | 2.88252780 |
| 44 | Pachygyria (HP:0001302) | 2.87169160 |
| 45 | Abnormality of the renal medulla (HP:0100957) | 2.86896405 |
| 46 | Hyperbilirubinemia (HP:0002904) | 2.82808959 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.81142695 |
| 48 | Acanthocytosis (HP:0001927) | 2.80380994 |
| 49 | Abnormality of complement system (HP:0005339) | 2.75446663 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.74617350 |
| 51 | Abnormality of the pons (HP:0007361) | 2.71569601 |
| 52 | Hyperammonemia (HP:0001987) | 2.68733096 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.67624992 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.65381581 |
| 55 | Abnormal biliary tract physiology (HP:0012439) | 2.64752541 |
| 56 | Bile duct proliferation (HP:0001408) | 2.64752541 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.60890113 |
| 58 | Ketosis (HP:0001946) | 2.56717793 |
| 59 | Focal motor seizures (HP:0011153) | 2.55198640 |
| 60 | Cystic liver disease (HP:0006706) | 2.54746674 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53840879 |
| 62 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53446947 |
| 63 | Hypoalphalipoproteinemia (HP:0003233) | 2.51864031 |
| 64 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.50811353 |
| 65 | Hypoplasia of the brainstem (HP:0002365) | 2.50811353 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.49300081 |
| 67 | Renal cortical cysts (HP:0000803) | 2.46119047 |
| 68 | Scanning speech (HP:0002168) | 2.44959839 |
| 69 | Polyphagia (HP:0002591) | 2.44827798 |
| 70 | Inability to walk (HP:0002540) | 2.39808018 |
| 71 | Steatorrhea (HP:0002570) | 2.39036723 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.38500138 |
| 73 | Blue irides (HP:0000635) | 2.37455268 |
| 74 | Severe muscular hypotonia (HP:0006829) | 2.35619076 |
| 75 | Generalized hypopigmentation of hair (HP:0011358) | 2.34514857 |
| 76 | Anencephaly (HP:0002323) | 2.31196843 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.30537623 |
| 78 | Chronic hepatic failure (HP:0100626) | 2.26535740 |
| 79 | Genetic anticipation (HP:0003743) | 2.25093229 |
| 80 | Chorioretinal atrophy (HP:0000533) | 2.24885539 |
| 81 | Sclerocornea (HP:0000647) | 2.24111977 |
| 82 | Spontaneous abortion (HP:0005268) | 2.23387457 |
| 83 | Enlarged kidneys (HP:0000105) | 2.22765459 |
| 84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22486469 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 2.22486469 |
| 86 | Hyperalaninemia (HP:0003348) | 2.22486469 |
| 87 | Abnormality of the labia minora (HP:0012880) | 2.20292475 |
| 88 | Metabolic acidosis (HP:0001942) | 2.20165624 |
| 89 | Decreased central vision (HP:0007663) | 2.19340729 |
| 90 | Attenuation of retinal blood vessels (HP:0007843) | 2.18753663 |
| 91 | Vaginal atresia (HP:0000148) | 2.15229622 |
| 92 | Postaxial foot polydactyly (HP:0001830) | 2.14728571 |
| 93 | Genital tract atresia (HP:0001827) | 2.13809073 |
| 94 | Status epilepticus (HP:0002133) | 2.12759835 |
| 95 | Poikilocytosis (HP:0004447) | 2.11227394 |
| 96 | Increased corneal curvature (HP:0100692) | 2.10146989 |
| 97 | Keratoconus (HP:0000563) | 2.10146989 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.08939080 |
| 99 | Poor coordination (HP:0002370) | 2.08478064 |
| 100 | Neonatal hypoglycemia (HP:0001998) | 2.07705865 |
| 101 | Agitation (HP:0000713) | 2.06384850 |
| 102 | Optic nerve hypoplasia (HP:0000609) | 2.05634085 |
| 103 | Patellar aplasia (HP:0006443) | 2.04608386 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 2.03999129 |
| 105 | Congenital hepatic fibrosis (HP:0002612) | 2.02931570 |
| 106 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.02650579 |
| 107 | Dry hair (HP:0011359) | 2.00896978 |
| 108 | Abnormality of the corticospinal tract (HP:0002492) | 2.00738936 |
| 109 | Hemiparesis (HP:0001269) | 1.98555518 |
| 110 | Neoplasm of the adrenal cortex (HP:0100641) | 1.98323267 |
| 111 | Postaxial hand polydactyly (HP:0001162) | 1.98322776 |
| 112 | Mitochondrial inheritance (HP:0001427) | 1.98313897 |
| 113 | Colon cancer (HP:0003003) | 1.97841626 |
| 114 | Vascular calcification (HP:0004934) | 1.97543211 |
| 115 | Acute necrotizing encephalopathy (HP:0006965) | 1.97277088 |
| 116 | Abnormal hair whorl (HP:0010721) | 1.96841869 |
| 117 | Epileptic encephalopathy (HP:0200134) | 1.96187770 |
| 118 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95730847 |
| 119 | Dandy-Walker malformation (HP:0001305) | 1.93997167 |
| 120 | Tubular atrophy (HP:0000092) | 1.93960997 |
| 121 | Glomerulonephritis (HP:0000099) | 1.93576031 |
| 122 | Abnormality of DNA repair (HP:0003254) | 1.93523331 |
| 123 | Specific learning disability (HP:0001328) | 1.93055913 |
| 124 | Oligodactyly (hands) (HP:0001180) | 1.92464630 |
| 125 | Menorrhagia (HP:0000132) | 1.91278969 |
| 126 | Hypoglycemic seizures (HP:0002173) | 1.91072687 |
| 127 | Osteomalacia (HP:0002749) | 1.90686280 |
| 128 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.90639432 |
| 129 | Limb dystonia (HP:0002451) | 1.90118273 |
| 130 | Broad-based gait (HP:0002136) | 1.89892979 |
| 131 | Gingival bleeding (HP:0000225) | 1.89301651 |
| 132 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88941125 |
| 133 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.88727406 |
| 134 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.88671194 |
| 135 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.86042111 |
| 136 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.86042111 |
| 137 | Hypothermia (HP:0002045) | 1.85253407 |
| 138 | Confusion (HP:0001289) | 1.82910533 |
| 139 | Focal seizures (HP:0007359) | 1.81887119 |
| 140 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.81500612 |
| 141 | Hepatocellular carcinoma (HP:0001402) | 1.80755129 |
| 142 | Concave nail (HP:0001598) | 1.79921911 |
| 143 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79252752 |
| 144 | Anterior segment dysgenesis (HP:0007700) | 1.79246958 |
| 145 | Polydipsia (HP:0001959) | 1.78688879 |
| 146 | Abnormal drinking behavior (HP:0030082) | 1.78688879 |
| 147 | Intestinal atresia (HP:0011100) | 1.78605117 |
| 148 | Male pseudohermaphroditism (HP:0000037) | 1.78294097 |
| 149 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78291813 |
| 150 | Cerebral palsy (HP:0100021) | 1.77897274 |
| 151 | Skin nodule (HP:0200036) | 1.77852136 |
| 152 | Polymicrogyria (HP:0002126) | 1.77772691 |
| 153 | Acute encephalopathy (HP:0006846) | 1.76827113 |
| 154 | Protruding tongue (HP:0010808) | 1.75892861 |
| 155 | Absent speech (HP:0001344) | 1.75629868 |
| 156 | Occipital encephalocele (HP:0002085) | 1.74540869 |
| 157 | Progressive inability to walk (HP:0002505) | 1.74383142 |
| 158 | Absent/shortened dynein arms (HP:0200106) | 1.74260931 |
| 159 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.74260931 |
| 160 | Methylmalonic acidemia (HP:0002912) | 1.72781878 |
| 161 | Mitral stenosis (HP:0001718) | 1.72755110 |
| 162 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71790626 |
| 163 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.71638160 |
| 164 | Opisthotonus (HP:0002179) | 1.71570137 |
| 165 | Large for gestational age (HP:0001520) | 1.71553759 |
| 166 | Increased CSF lactate (HP:0002490) | 1.70955343 |
| 167 | Failure to thrive in infancy (HP:0001531) | 1.70711025 |
| 168 | Elevated hepatic transaminases (HP:0002910) | 1.70516913 |
| 169 | Abnormality of the axillary hair (HP:0100134) | 1.70318384 |
| 170 | Abnormality of secondary sexual hair (HP:0009888) | 1.70318384 |
| 171 | Lethargy (HP:0001254) | 1.70146287 |
| 172 | Hepatocellular necrosis (HP:0001404) | 1.69777022 |
| 173 | Tubulointerstitial nephritis (HP:0001970) | 1.69569961 |
| 174 | Rib fusion (HP:0000902) | 1.69001778 |
| 175 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.68750428 |
| 176 | Symptomatic seizures (HP:0011145) | 1.67159100 |
| 177 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.63843126 |
| 178 | Brushfield spots (HP:0001088) | 1.63481813 |
| 179 | Gaze-evoked nystagmus (HP:0000640) | 1.62693235 |
| 180 | Drooling (HP:0002307) | 1.62552229 |
| 181 | Excessive salivation (HP:0003781) | 1.62552229 |
| 182 | Systemic lupus erythematosus (HP:0002725) | 1.61643905 |
| 183 | Progressive external ophthalmoplegia (HP:0000590) | 1.58806926 |
| 184 | Pancreatitis (HP:0001733) | 1.58422686 |
| 185 | Impaired vibratory sensation (HP:0002495) | 1.58282430 |
| 186 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.56522272 |
| 187 | Alkalosis (HP:0001948) | 1.56518365 |
| 188 | Cerebral edema (HP:0002181) | 1.56235019 |
| 189 | Abnormality of vitamin metabolism (HP:0100508) | 1.56020904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.54656752 |
| 2 | INSRR | 3.27816812 |
| 3 | MAP4K2 | 3.08229914 |
| 4 | SIK3 | 2.73020942 |
| 5 | TNIK | 2.60643836 |
| 6 | PRPF4B | 2.41301081 |
| 7 | MAP2K7 | 2.30891847 |
| 8 | WNK4 | 2.26100598 |
| 9 | AKT3 | 2.24261361 |
| 10 | MARK1 | 2.14922912 |
| 11 | BCR | 2.11672143 |
| 12 | NEK6 | 2.08363823 |
| 13 | TLK1 | 2.04615283 |
| 14 | FGFR2 | 1.90132281 |
| 15 | SGK2 | 1.85263366 |
| 16 | STK16 | 1.80813514 |
| 17 | FGFR4 | 1.77877433 |
| 18 | TRIM28 | 1.76478415 |
| 19 | EPHA4 | 1.66107444 |
| 20 | TXK | 1.63918257 |
| 21 | SGK494 | 1.55381370 |
| 22 | SGK223 | 1.55381370 |
| 23 | YES1 | 1.53181407 |
| 24 | IRAK2 | 1.51453206 |
| 25 | ERBB4 | 1.47883004 |
| 26 | NTRK3 | 1.47687172 |
| 27 | MAP3K14 | 1.45338377 |
| 28 | GRK1 | 1.43060889 |
| 29 | SRPK1 | 1.41536118 |
| 30 | IRAK3 | 1.40604740 |
| 31 | OXSR1 | 1.39149748 |
| 32 | ZAK | 1.36973517 |
| 33 | NUAK1 | 1.33462037 |
| 34 | MKNK2 | 1.33283709 |
| 35 | PKN1 | 1.29695191 |
| 36 | SIK2 | 1.29608611 |
| 37 | ADRBK2 | 1.26862169 |
| 38 | MAPK13 | 1.22881603 |
| 39 | KSR1 | 1.20142360 |
| 40 | TAOK3 | 1.17744174 |
| 41 | IRAK1 | 1.13804948 |
| 42 | MAP3K4 | 1.13417822 |
| 43 | MAP2K4 | 1.13320726 |
| 44 | SGK3 | 1.13095276 |
| 45 | BRD4 | 1.09792878 |
| 46 | PAK3 | 1.07355071 |
| 47 | CAMKK2 | 1.06004355 |
| 48 | MAPK7 | 1.05703808 |
| 49 | CDK19 | 1.01827613 |
| 50 | CDK3 | 0.99552152 |
| 51 | VRK1 | 0.98164371 |
| 52 | BMPR2 | 0.93955600 |
| 53 | PRKCG | 0.93302666 |
| 54 | SIK1 | 0.93048437 |
| 55 | NTRK2 | 0.92732736 |
| 56 | ACVR1B | 0.92174452 |
| 57 | RPS6KA5 | 0.91784398 |
| 58 | DYRK3 | 0.90454182 |
| 59 | NME1 | 0.90096804 |
| 60 | DYRK2 | 0.89380560 |
| 61 | EIF2AK1 | 0.87694637 |
| 62 | FES | 0.87437304 |
| 63 | IRAK4 | 0.85604596 |
| 64 | EPHA3 | 0.83828662 |
| 65 | TNK2 | 0.81022878 |
| 66 | EIF2AK2 | 0.79631115 |
| 67 | PRKCE | 0.77693374 |
| 68 | CSNK1A1L | 0.77116602 |
| 69 | CAMK1G | 0.75624744 |
| 70 | PINK1 | 0.75445954 |
| 71 | ADRBK1 | 0.74474617 |
| 72 | DYRK1B | 0.74194267 |
| 73 | MAP2K6 | 0.74121538 |
| 74 | CAMK2B | 0.73081452 |
| 75 | DAPK2 | 0.72722036 |
| 76 | CSNK1G1 | 0.71766170 |
| 77 | CCNB1 | 0.71232908 |
| 78 | PHKG2 | 0.70871246 |
| 79 | PHKG1 | 0.70871246 |
| 80 | MAP3K12 | 0.68824450 |
| 81 | MAP4K1 | 0.68431191 |
| 82 | STK11 | 0.66329403 |
| 83 | TIE1 | 0.65840502 |
| 84 | ERBB2 | 0.65165360 |
| 85 | PRKAA2 | 0.65099503 |
| 86 | UHMK1 | 0.63887616 |
| 87 | CSNK1G3 | 0.63251440 |
| 88 | PRKCQ | 0.62172410 |
| 89 | BCKDK | 0.61757704 |
| 90 | RPS6KB1 | 0.60863087 |
| 91 | CAMK2G | 0.60792401 |
| 92 | MAPKAPK5 | 0.59861068 |
| 93 | PNCK | 0.59501432 |
| 94 | PRKCZ | 0.59131904 |
| 95 | PIK3CA | 0.58992113 |
| 96 | STK39 | 0.57884546 |
| 97 | SGK1 | 0.56673170 |
| 98 | CSNK1G2 | 0.56449014 |
| 99 | WNK3 | 0.56056324 |
| 100 | ERBB3 | 0.55657897 |
| 101 | PTK2B | 0.55616306 |
| 102 | CAMK4 | 0.55464772 |
| 103 | FRK | 0.55035368 |
| 104 | FGFR3 | 0.54922004 |
| 105 | CAMK1D | 0.54386668 |
| 106 | BMPR1B | 0.51801267 |
| 107 | DYRK1A | 0.51362464 |
| 108 | CAMK2A | 0.51085840 |
| 109 | CAMK1 | 0.50374047 |
| 110 | TESK2 | 0.50319813 |
| 111 | PLK2 | 0.50145513 |
| 112 | IKBKE | 0.46952896 |
| 113 | CSNK1D | 0.45729317 |
| 114 | ATR | 0.45164039 |
| 115 | MUSK | 0.44549116 |
| 116 | PIK3CG | 0.44102821 |
| 117 | MARK3 | 0.43556650 |
| 118 | MAPK15 | 0.42397590 |
| 119 | PAK6 | 0.42008126 |
| 120 | FER | 0.41322022 |
| 121 | MAP3K11 | 0.40786519 |
| 122 | MINK1 | 0.40693400 |
| 123 | MKNK1 | 0.40536184 |
| 124 | CDK5 | 0.40148312 |
| 125 | CSNK1A1 | 0.38837719 |
| 126 | PRKACA | 0.38709747 |
| 127 | TEC | 0.38641449 |
| 128 | CAMKK1 | 0.38445757 |
| 129 | WNK1 | 0.38098212 |
| 130 | PRKACG | 0.37794546 |
| 131 | MARK2 | 0.37760631 |
| 132 | MAP3K13 | 0.37605124 |
| 133 | TYRO3 | 0.36900009 |
| 134 | MAPK12 | 0.35805604 |
| 135 | CAMK2D | 0.35497910 |
| 136 | PRKG1 | 0.35361777 |
| 137 | EPHB1 | 0.35064566 |
| 138 | MAPK4 | 0.34325736 |
| 139 | RPS6KA4 | 0.33310798 |
| 140 | PRKAA1 | 0.33301910 |
| 141 | NLK | 0.32941096 |
| 142 | CHUK | 0.32902254 |
| 143 | PRKCA | 0.32221539 |
| 144 | PIM1 | 0.32106410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40385429 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.97402352 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76289771 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75849587 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.70576906 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66581547 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62292442 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55102733 |
| 9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.50834211 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.46730463 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34104407 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33775636 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.19155782 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.16930453 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10344157 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06875213 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03601243 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03150244 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02021778 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.95332282 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95183351 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.95033597 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.91213238 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.89997271 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89272766 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89047303 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86088979 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77992062 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73881050 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73016754 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72758103 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.72576236 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70889769 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70679659 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.64311477 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.62137796 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60247316 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.59451225 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57784136 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56095510 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53976285 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53597605 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.52675734 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51433060 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51073823 |
| 46 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46552532 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45693784 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45488306 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43828192 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.43470753 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.36787089 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.35076050 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33623479 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33589076 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.33379657 |
| 56 | Alcoholism_Homo sapiens_hsa05034 | 1.26462231 |
| 57 | Protein export_Homo sapiens_hsa03060 | 1.13925657 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13762923 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12455522 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.07212748 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06745819 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05844959 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 1.02243496 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 1.00322117 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98953016 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98903404 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97431792 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96837642 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93043720 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.91941473 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.86311470 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85565359 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79484188 |
| 74 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79245070 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75063170 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74395459 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74193725 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.72866356 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.72637188 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72088128 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71301578 |
| 82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68337029 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.68186133 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61516768 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61146261 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60180050 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60133429 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58422767 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57557644 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56336382 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56188099 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52323214 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52153118 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52034843 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.52011374 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51810276 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50292475 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48759061 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47720051 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46551477 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45788031 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.43482571 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42411893 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39136347 |
| 105 | Base excision repair_Homo sapiens_hsa03410 | 0.39115575 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38933772 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38332572 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38232412 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37860109 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.36092712 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35796139 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34876422 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34764102 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34135646 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33401979 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33043955 |
| 117 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.32696655 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32512760 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31775068 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30630894 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28657034 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28611726 |
| 123 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28179481 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28156928 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28111510 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27406580 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26007776 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25900705 |
| 129 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24742347 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21809742 |
| 131 | Axon guidance_Homo sapiens_hsa04360 | 0.21756962 |
| 132 | Carbon metabolism_Homo sapiens_hsa01200 | 0.21510703 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20550056 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19552461 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18057908 |
| 136 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13106521 |
| 137 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12907311 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.12905605 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12764696 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10173810 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09201488 |
| 142 | Cocaine addiction_Homo sapiens_hsa05030 | 0.05658075 |
| 143 | Insulin secretion_Homo sapiens_hsa04911 | 0.05249275 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.04365803 |
| 145 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.02925796 |
| 146 | Circadian entrainment_Homo sapiens_hsa04713 | 0.02816859 |
| 147 | Circadian rhythm_Homo sapiens_hsa04710 | 0.02622688 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01198682 |
| 149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.00514567 |

